Looking to restart scheduled procedures? Communication with these 3 groups is essential.

In the midst of this epidemic, where fear and rumors thrive, only strong, accurate, and effective communication will break through the noise of an inevitably staccato reopening process. To help ease the transition, Advisory Board's Ken Leonczyk and Matthew Stevens outline ways health systems can communicate effectively with local government, the local community, and staff.

Read More

Why it's so hard to stay in shape while sheltering at home

With the new coronavirus epidemic forcing many Americans to stay at home, it can be difficult to stay in shape—but while regaining your fitness may be difficult, it's not impossible, Amanda Loudin reports for the Washington Post.

While America's Covid-19 epidemic surged, the health care industry lost 1.4M jobs last month

The health care industry lost a record 1.4 million jobs in April, as many hospitals postponed elective procedures and doctors' offices closed their doors, according to a preliminary report released Friday by the U.S. Bureau of Labor Statistics.

Weekly review: Why Covid-19 hits some places so hard—and not others

What's behind Covid-19's mysterious "second-week crash," five tips to help stop zoning out in virtual meetings, and more.

Inside the Trump admin's revised plan to distribute remdesivir

After providers raised concerns over the Trump administration's plan to distribute remdesivir, which is the only drug that's cleared to treat patients with Covid-19, HHS on Saturday announced state health departments will be responsible for doling out the drug.

Covid-19 roundup: FDA grants EUA for first at-home saliva test kit for new coronavirus

FDA issues new guidelines for at-home Covid-19 diagnostic tests, Ford and 3M begin distributing respirators to providers, and more.

Around the nation: Drugmaker settles price fixing allegations for $24M

According to the Department of Justice, Apotex as part of a settlement agreement has admitted that it worked with other drug companies to fix the price of its cholesterol drug pravastatin from 2013 to 2015, in today's bite-sized hospital and health industry news from California, the District of Columbia, and New York.